{"schema_version":"secwatch.filing_event.v1","accession":"0001388658-23-000048","form_type":"8-K","ticker":"IRTC","cik":"0001388658","company_name":"iRhythm Holdings, Inc.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.666046+00:00","generated_at":"2026-06-15T21:23:48.885131+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"iRhythm reports Q1 revenue $111.4M (+20.6% YoY); updates FY2023 guidance to $480-$490M","bullets":["Revenue $111.4M (+20.6% YoY); gross margin 67.9%, up 100 bps from 66.9%.","Net loss $39.1M ($1.29 loss per share) vs $50.6M ($1.71 loss per share) in Q1 2022.","Adjusted net loss $33.4M ($1.10 loss per share) vs $23.7M ($0.80 loss per share) in Q1 2022.","FY2023 revenue guidance raised to $480-$490M (17%-19% growth); gross margin 69%-70% expected.","CAMELOT study at ACC.23/WCC showed Zio XT highest diagnostic yield, lowest retesting rates."],"urls":{"canonical":"https://secwatch.observer/filing/0001388658-23-000048","json":"https://secwatch.observer/filing/0001388658-23-000048.json","markdown":"https://secwatch.observer/filing/0001388658-23-000048.md","text":"https://secwatch.observer/filing/0001388658-23-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1388658/000138865823000048/0001388658-23-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1388658/000138865823000048/irtc-20230504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T21:23:48.885131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"10f432856f992c0100d699e8b7aebaa4becebb0a","claim":"iRhythm Holdings, Inc. reported Full year 2023 results: revenue $480 million to $490 million.","evidence_excerpt":"Updated fiscal year 2023 revenue guidance to a range of approximately $480 million to $490 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1388658/000138865823000048/0001388658-23-000048-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full year 2023"},{"label":"Revenue","value":"$480 million to $490 million"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"18d88302789c48a2b34f52fb7a3da1fdb0585861","claim":"iRhythm Holdings, Inc. reported Three months ended March 31, 2023 results: net income -$33.4 million, EPS -$1.10.","evidence_excerpt":"Revenue of $111.4 million, a 20.6% increase compared to first quarter 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1388658/000138865823000048/0001388658-23-000048-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Three months ended March 31, 2023"},{"label":"Net income","value":"-$33.4 million"},{"label":"EPS","value":"-$1.10"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"18d88302789c48a2b34f52fb7a3da1fdb0585861","claim":"iRhythm Holdings, Inc. reported Three months ended March 31, 2023 results: net income -$33.4 million, EPS -$1.10.","evidence_excerpt":"Net loss for the first quarter of 2023 was $39.1 million, or a loss of $1.29 per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1388658/000138865823000048/0001388658-23-000048-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Three months ended March 31, 2023"},{"label":"Net income","value":"-$33.4 million"},{"label":"EPS","value":"-$1.10"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"18d88302789c48a2b34f52fb7a3da1fdb0585861","claim":"iRhythm Holdings, Inc. reported Three months ended March 31, 2023 results: net income -$33.4 million, EPS -$1.10.","evidence_excerpt":"Adjusted net loss for th e first quarter of 2023 was $33.4 million, or a loss of $1.10 per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1388658/000138865823000048/0001388658-23-000048-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Three months ended March 31, 2023"},{"label":"Net income","value":"-$33.4 million"},{"label":"EPS","value":"-$1.10"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}